# Parkervision Inc: Form 10-Q for the period ended Mar 31, 2013

- Company: [Parkervision Inc](/companies/prkr.md) (CIK 914139)
- Form: 10-Q
- Filed: 2013-05-09
- Accepted by EDGAR: May 9, 2013, 20:08 ET
- Period: 2013-03-31
- Accession: 0000914139-13-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914139/000091413913000008/prkr-20130331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914139/000091413913000008/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2013-01-01 to 2013-03-31 | $0 | us-gaap:CostOfServices |
| Gross profit | 3 months, 2013-01-01 to 2013-03-31 | $0 | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-01-01 to 2013-03-31 | $2.4m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 3 months, 2013-01-01 to 2013-03-31 | $2.2k | us-gaap:InterestExpense |
| Net income | 3 months, 2013-01-01 to 2013-03-31 | −$6.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-01-01 to 2013-03-31 | −$0.08 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2013-01-01 to 2013-03-31 | −$4.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2013-01-01 to 2013-03-31 | $22.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-03-31 | $307.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-03-31 | $19.0m | us-gaap:AssetsCurrent |
| Total assets | at 2013-03-31 | $28.3m | us-gaap:Assets |
| Current liabilities | at 2013-03-31 | $2.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-03-31 | $2.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2013-03-31 | $26.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 13,802 characters.

#### Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public. This report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, statements about our future plans, objectives, and expectations contained in this Item. When used in this report and in future filings by us with the Securities and Exchange Commission (“SEC”), the words or phrases “will likely result”, “management expects”, “we expect”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.” Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2012 (the “Annual Report”) and in this Item 2 of Part I of this quarterly report. Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key business and sales relationships, reliance on our intellectual property, the outcome of our intellectual property litigation and the ability to obtain adequate financing in the future. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

#### Overview

We are in the business of innovating fundamental wireless technologies. We design, develop and market our proprietary RF technologies and products for use in semiconductor circuits for wireless communication products. Since 2005, we have generated no product or royalty revenue from our wireless technologies. We have made significant investments in developing and protecting our technologies and products, the returns on which are dependent upon the generation of future revenues for realization.

We are currently engaged in patent litigation with Qualcomm for their alleged infringement of a number of our patents that relate to our receiver intellectual property. We believe the outcome of this litigation is an important factor in our ability to generate meaningful revenue from certain of our receiver technologies. Therefore, we have devoted substantial resources to this litigation, and expect to continue to do so in the foreseeable future. The trial is scheduled to begin in October 2013. Although our litigation team is working on a partial contingency basis, we expect to incur significant costs for legal and expert fees related to this litigation in 2013 and possibly beyond.

We have also devoted substantial resources to the development of RF products that interface with VIA Telecom Inc.’s (“VIA’s”) baseband processors. In March 2013, we entered into a development agreement with VIA for the development and support of drivers between VIA’s baseband products and our RF chipsets and the ongoing support and maintenance of the custom interfaces between our products. We anticipate that we will pay VIA an aggregate of approximately $1.3 million under this agreement in 2013, provided that VIA meets all of the future development milestones specified in the agreement. We have been working with VIA and a mutual customer since 2011 on the design and test of a mobile handset solution using our RF chipset. We believe our recent development agreement with VIA will provide the product integration and support necessary to incorporate our RF chipsets into one or more of the mutual customer’s mobile products. In the event we secure product orders for our RF chipsets, we expect that available working capital will be used for initial production start-up costs, including test programs and production tooling.

#### Liquidity and Capital Resources

On March 26, 2013, we completed the sale of an aggregate of 4,715,000 shares of our common stock, at a price of $3.25 per share, under a shelf registration statement (File No. 333-183713) and a Rule 426(b) registration statement (File No. 333-187403), in an underwritten offering with Ladenburg Thalmann & Co. Inc. who acted as underwriter. The offering represented 5.4% of our outstanding common stock on an after-issued basis. The aggregate net proceeds from this offering, after deduction of placement agent fees and other offering costs, were approximately $14.3 million.

As of March 31, 2013, we had working capital of approximately $17.1 million which represented an increase of approximately $9.9 million from working capital at December 31, 2012. This increase in working capital is a result of approximately $14.3 million in net proceeds from the March 2013 offering and $0.2 million in proceeds from the exercise of stock options and warrants, less $4.8 million to fund operations and $0.2 million used for patents and fixed assets during the three months ended March 31, 2013. Our use of cash to fund operations increased approximately $1.8 million, or 57%, during the three months ended March 31, 2013 when compared to the same period in 2012. This increase in use of cash is primarily the result of an increase in litigation related fees and expenses.

Our future business plans call for continued investment in sales, marketing, customer support and product development for our technologies and products, as well as investment in continued protection of our intellectual property, including the prosecution of new patents and defense of existing patents. Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies, our ability to secure a reasonable share of the market through additional product offerings with our customers, our ability to secure new customers for our products or technologies, and/or our ability to defend our intellectual property.

Any revenue generated from the sale of our RF chipsets in 2013 will not be sufficient to cover our operational expenses, and we expect that our continued losses and use of cash will be funded from our available working capital. In addition, we expect that available working capital may be used for initial production start-up costs, including test programs and production tooling, and for continued litigation expenses to defend our intellectual property.

Our current capital resources may be sufficient to support our liquidity requirements through 2013; however, these resources may not be sufficient to support our liquidity requirements for the next twelve months and beyond without further cost containment measures that, if implemented, may jeopardize our future growth plans, including our ability to support initial production of our products. We believe we may be able to meet future liquidity needs through the issuance of equity securities in public offerings or private placements or through short or long-term debt financing, although there can be no assurance that such financing will be available to us. We currently have no significant long-term debt obligations.

The long-term continuation of our business plan through 2013 and beyond is dependent upon the generation of sufficient revenues from our technologies and products to offset expenses. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or further reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or further reduce operating costs could have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

#### Results of Operations for Each of the Three Months Ended March 31, 2013 and 2012

#### Revenue and Gross Margin

We had no product or royalty revenue for the three months ended March 31, 2013 or 2012. We have been working with one of VIA’s largest mobile handset customers on the design and test of a handset solution incorporating our technology, the successful completion of which, we believe, will lead to the incorporation of our technology into one or more of this customer’s products. To the extent that our technology is incorporated in the form of integrated circuits supplied by us, additional working capital may be needed to support production start-up costs including test programs and production tooling.

#### Research and Development Expenses

Research and development expenses consist primarily of engineering and related management and support personnel costs; fees for outside engineering design services which we use from time to time to supplement our internal resources; amortization and depreciation expense related to our patents and other assets used in product development; prototype production and materials costs, which represent the fabrication and packaging costs for prototype integrated circuits, as well as the cost of supporting components for prototype board development; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and rent and other overhead costs for our engineering design facility. Personnel costs include share-based compensation amounts which have been determined based on the grant date fair value of equity-based awards to our employees and then recorded to expense over the vesting period of the award.

Our research and development expenses increased approximately $327,000, or 16%, during the three months ended March 31, 2013 when compared to the same period in 2012. This increase is primarily due to an increase in share-based compensation expense of approximately $278,000 as a result of long-term incentive equity awards granted to engineering executives and employees in July 2012. In addition, prototype production costs increased approximately $156,000 as a result of ongoing improvements to our integrated circuits.

We expect a significant percentage of our current working capital will continue to be invested in our research and product development activities. However, cash expenditures for research and product development activities will fluctuate on a quarter to quarter basis depending on the timing of various projects.

#### Marketing and Selling Expenses

Marketing and selling expenses consist primarily of marketing and sales personnel costs, including share-based compensation and travel costs, and outside professional fees. Marketing and selling expenses changed by less than 1% during the three months ended March 31, 2013 when compared to the same period in 2012.

#### General and Administrative Expenses

General and administrative expenses consist primarily of executive, director, finance and administrative personnel costs, including share-based compensation, and costs incurred for insurance, shareholder relations and outside professional services, including litigation and other legal services.

General and administrative expenses increased approximately $2,071,000, or 126%, during the three months ended March 31, 2013 when compared to the same period in 2012. This increase is primarily due to an increase in share-based compensation expense of approximately $1,103,000 and an increase in outside legal fees of approximately $852,000.

This increase in outside legal fees is primarily the result of fees and other expenses related to our patent infringement litigation against Qualcomm. The increase in share-based compensation expense is the result of long-term equity incentive awards granted to executive, other administrative employees, and outside directors in July 2012 as well as the recognition of approximately $621,000 of expense recognized upon the March 2013 vesting of performance based RSUs issued to a third-party in 2011.

#### Net Loss and Net Loss per Common Share

Our net loss increased approximately $2,394,000, or 59%, during the three months ended March 31, 2013 when compared to the same period in 2012. This increase is primarily the result of a $1,436,000 increase in total company share-based compensation expense along with an $852,000 increase in outside legal fees, primarily related to our patent infringement litigation.

On a per share basis, our net loss for the three months ended March 31, 2013 increased $0.02, or 33% per common share when compared to the same period in 2012 as a result of a $2,400,000, or 59% increase in operating expenses, offset by a 23% increase in the weighted average shares outstanding for the period.

#### Off-Balance Sheet Transactions, Arrangements and Other Relationships

As of March 31, 2013, we had outstanding warrants to purchase 2,331,179 shares of common stock that were issued in connection with the sale of equity securities in various public and private placement transactions in 2009, 2010, and 2011. These warrants have exercise prices ranging from $0.54 to $1.88 per share, with a weighted average exercise price of $0.80 and a weighted average remaining contractual life of approximately 2.4 years. The estimated fair value of these warrants of $982,444 is included in shareholders’ equity in our balance sheets.

#### Critical Accounting Policies

There have been no changes in critical accounting policies from those stated in our Annual Report.

## Market risk

As filed, 163 characters.

For the three months ended March 31, 2013, there were no material changes from the market risk information disclosed under Item 7A of Part II of our Annual Report.

## Controls and procedures

As filed, 931 characters.

#### Evaluation of Disclosure Controls and Procedures

As of March 31, 2013, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of March 31, 2013.

#### Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(e) under the Exchange Act that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 395 characters.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report. In addition to the information in this quarterly report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

Filed May 9, 2013.
Source: SEC EDGAR, the filing index for accession 0000914139-13-000008. Last ingested by Listed: Nov 11, 2026, 01:56 ET. No prices; not investment advice.
